کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1222499 | 1494672 | 2012 | 5 صفحه PDF | دانلود رایگان |
The combined use of 5-fluorouracil and paclitaxel is common in clinical trials. However, there are few methods for simultaneous determination of 5-fluorouracil and paclitaxel; most reported approaches can only quantitate either 5-fluorouracil or paclitaxel. This paper proposes a new gradient elution HPLC method for simultaneous determination of 5-fluorouracil and paclitaxel using a photodiode array detector, C18 column (250 mm × 4.6 mm, 5 μm) with methanol and 0.5% H3PO4 aqueous solution as the mobile phase components. The injection volume was 50 μl and the column temperature was maintained at 30 °C. The method was validated according to USP Category I requirements. The validation characteristics included system suitability, linearity, analytical range, LOD, LOQ, accuracy, precision, specificity, stability, ruggedness and robustness. The calibration curves exhibited linear concentration ranges of 0.2–40 μg/ml for 5-fluorouracil and 1.5–150 μg/ml for paclitaxel with correlation coefficients larger than 0.99990. The lower limits of quantitation were 2 ng/ml for 5-fluorouracil and 0.75 μg/ml for paclitaxel, respectively. The intra and inter-day precision and accuracy were found to be well within acceptable limits (i.e., 5%). The results demonstrate that this method is reliable, reproducible and suitable for simultaneous quantitation of the two drugs in the release media of 5-fluorouracil/paclitaxel-co-eluting stents.
► We propose a new gradient elution HPLC method for simultaneous determination of 5-FU and PTX.
► It is suitable for simultaneous quantitation of 5-FU and PTX in the release media of stents.
► It can be applied in quantitative analysis of drug sustained release preparations.
Journal: Journal of Pharmaceutical and Biomedical Analysis - Volume 59, 5 February 2012, Pages 179–183